Effect of efaroxan on the expression of a Ras homologue in islet β cells

( views:112, downloads:0 )
Author:
()
Morgan NG()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 10, Issue 03, 2002
DOI:
Key Word:

Abstract: Objective To investigate whether a Ras homologue, Rhes, is expressed and the effect of efaroxan on Rhes expression in islet β cells. Methods Reverse transcription and polymerese chain reaction(RT PCR)was employed to detect Rhes transcript in clonal rat insulin releasing cells (RINm5F and BRIN BD11 cells) and intact isolated rat islets. Insulin release was measured after exposure to efaroxan and/or KU14R for 2hr under the condition that BRIN BD11 cells were precultured with or without efaroxna for 24 hr. Results (1) Rhes is expressed in RINm5F cells and BRIN BD11 cells and isolated rat islets. (2) Rhes expression was down regulated by efaroxan. KU14R, a structurally related molecule to efaroxan, had no effect on Rhes expression, however, it completely blocked the down regulation of Rhes expression induced by efaroxan. (3) Efaroxan induced a state of functional desensitization in clonal BRIN BD11 cells after 24 h exposure. (4)Unlike being in isolated human and rat islets, KU14R itself stimulated insulin secretion in clonal BRIN BD11 cells. Conclusion Rhes is expressed in islet β cells. Rhes represents an imidazoline regulated molecule that could be involved in mediating the insulin secretory response to efaroxan.

  • [1]Chan SL, Brown CA, Morgan NG. Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Eur J Pharmacol,1993, 230:375-378.
  • [2]Falk JD, Vargin P,Foye PE, et al.Rhes: a striatal-specific Ras hongmolog related to Dexras 1. J Neuroscience Rese, 1999,57:782-788.
  • [3]Kemppainen RJ, Behrend EN. Dexamethasone rapidly induces a novel Ras superfamily member-related gene in ArT-20 cells. J Biol Chem, 1998, 273:3129-3131.
  • [4]Proks P, Ashcroft FM. Phentolamine bloch of KATP channel is mediated by Kir 6.2. Proc Natl Acad Sci USA, 1997, 94:11716-11720.
  • [5]Chan SL, Pallett AL, Clews J, et al. Characterisation of new efaroxan derivatives for use in purification of imidazoline-binding sites. Eur J Pharmacol, 1998, 14:67-76.
  • [6]Chan SL, Mourtada M, Morgan NG. Characterization of a KATP channel-Iindependent pathway involved in potentiation of insulin secretion by efaroxan. Diabetes, 2001, 50:340-347.
  • [7]Morgan NG, Chan SL. Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential targets for the development of new insulin secretagogues? Current Pharm Desi, 2001, 7: 1413-1431.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn